✦ LIBER ✦

Human immunodeficiency virus type 1 protease inhibitor attenuates Candida albicans virulence properties in vitro

✍ Scribed by Andreas Gruber; Cornelia Speth; Elisabeth Lukasser-Vogl; Robert Zangerle; Margarete Borg-von Zepelin; Manfred P Dierich; Reinhard Würzner

Book ID: 108405434
Publisher: Elsevier Science
Year: 1999
Tongue: English
Weight: 225 KB
Volume: 41
Category: Article
ISSN: 0162-3109
DOI: 10.1016/s0162-3109(99)00035-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Growth in human immunodeficiency virus t

Growth in human immunodeficiency virus type 1- infected children treated with protease inhibitors

✍ Felicitas Steiner; Christian Kind; Christoph Aebi; Claire-Anne Wyler-Lazarevitch 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 112 KB

Antiretroviral therapy with protease inh

Antiretroviral therapy with protease inhibitors in human immunodeficiency virus type 1- and human herpesvirus 8-coinfected patients

✍ De Milito, Angelo; Catucci, Marinunzia; Venturi, Giulietta; Romano, Laura; Incan 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB 👁 2 views

Human herpesvirus 8 (HHV-8) is believed to play a role in the pathogenesis of Kaposi's sarcoma (KS) and possibly in other proliferative disorders often associated with human immunodeficiency virus type 1 (HIV-1) infection. Recent case reports have indicated resolution of KS and clearance of HHV-8 DN

An ultrasensitive human immunodeficiency

An ultrasensitive human immunodeficiency virus type 1 protease radioimmuno rate assay with a potential for monitoring blood levels of protease inhibitors in acquired immunodeficiency disease syndrome patients

✍ David B. Evans; Anne F. Vosters; Thomas J. McQuade; Satish K. Sharma 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 558 KB

The angiotensin I-based peptide Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Leu-Glu-Glu-Ser yields angiotensin I (Ang I) and Leu-Glu-Glu-Ser upon hydrolysis by the human immunodeficiency virus type 1 (HIV-1) protease, but not by human renin. N-terminal sequencing of the reaction products showed that the

Effect of human immunodeficiency virus t

Effect of human immunodeficiency virus type 1 protease inhibitor therapy and subtype on development of resistance in subtypes B and G

✍ Ana Carolina Palma; Ana Barroso Abecasis; Jurgen Vercauteren; Ana Patricia Carva 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 315 KB

Europe is currently observing a significant rise in non-B subtypes. Consequently, the effect of genetic variability on therapy response or genotypic resistance interpretation algorithms is an emerging concern. The purpose of this study is to investigate the amino acid substitutions selected under dr

Perinatal infection by human immunodefic

Perinatal infection by human immunodeficiency virus type 1 (HIV–1): Relationship between proviral copy number in vivo, viral properties in vitro, and clinical outcome

✍ Anita De Rossi; Marcella Pasti; Fabrizio Mammano; Lucia Ometto; Carlo Giaquinto; 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 694 KB

## Abstract Human immunodeficiency virus type 1 (HIV‐1) isolates from 25 perinatally HIV‐1 infected children were classified according to their capacity to replicate in vitro as rapid (R), intermediate (S/R) and slow (S) variants. R‐type viruses replicated on peripheral blood mononuclear cells (PBM